Shreeji Healthcare

AXEPTA 60MG TABLET contains Atomoxetine which belongs to the group of medicines called Psychostimulants. It is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults, adolescents and in children (aged above 6 years).

Atomoxetine is a selective NRI medicine used to treat attention deficit hyperactivity disorder (ADHD) to help improve attention and reduce hyperactivity and impulsiveness. Atomoxetine is thought to work by selectively blocking a protein (pre-synaptic norepinephrine transporter) that affects chemicals in the brain and nerves involved in hyperactivity and impulse control; blocking this protein may improve ADHD symptoms. Atomoxetine is usually used together with psychological, educational, and social measures. 

Atomoxetine is not a stimulant medication and is not a controlled substance.

Atomoxetine is from a group of medicines called selective norepinephrine reuptake inhibitors (NRIs). Strattera, the original brand of atomoxetine, received FDA approval on November 26, 2002, for the treatment of Attention-Deficit/Hyperactivity Disorder. Atomoxetine has not been studied in children less than 6 years old. Strattera is now available as a generic under the active ingredient name atomoxetine.